New York State Common Retirement Fund’s Marker Therapeutics MRKR Stock Holding History

New York State Common Retirement Fund’s Portfolio MRKR Stock Details MRKR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-25	Closed	-$1K	–	3460
2021 Q2	$1K	Sell	25 -1,375	-98%	-$36.2K	﹤0.01%	3434
2021 Q1	$31K	Hold	1,400	–	–	﹤0.01%	3262
2020 Q4	$20K	Hold	1,400	–	–	﹤0.01%	3247
2020 Q3	$21K	Hold	1,400	–	–	﹤0.01%	3203
2020 Q2	$29K	Hold	1,400	–	–	﹤0.01%	3185
2020 Q1	$27K	Hold	1,400	–	–	﹤0.01%	3076
2019 Q4	$40K	Sell	1,400 -1,360	-49%	-$49.5K	﹤0.01%	3147
2019 Q3	$141K	Hold	2,760	–	–	﹤0.01%	2925
2019 Q2	$219K	Buy	+2,760	New	+$164K	﹤0.01%	2770

Other funds holding MRKR

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

ACM

Aisling Capital Management New York $476M AUM 128.63% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

KCM

Kennedy Capital Management St Louis, Missouri $4.72B AUM 36.69% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

New York State Common Retirement Fund's MRKR Position: Q3 2021 in Review

New York State Common Retirement Fund sold out of Marker Therapeutics (MRKR) in Q3 2021, closing a stake of 25 shares — an estimated $1K sold.

New York State Common Retirement Fund first reported a position in MRKR in Q2 2019 and held it in 9 quarters. The position peaked at $219K in Q2 2019. 63 funds tracked by Wall St. Rank hold MRKR as of Q3 2021.

New York State Common Retirement Fund reported no remaining Marker Therapeutics position as of Q3 2021 after selling out during the quarter.
New York State Common Retirement Fund sold 25 Marker Therapeutics shares in Q3 2021, an estimated $1K.
New York State Common Retirement Fund first reported a position in Marker Therapeutics in Q2 2019 and held it in 9 quarters.
New York State Common Retirement Fund's Marker Therapeutics position peaked at $219K in Q2 2019.
63 funds tracked by Wall St. Rank held Marker Therapeutics as of Q3 2021.

Based on New York State Common Retirement Fund's 13F filing for Q3 2021, filed 2 Nov 2021.